Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Stockholders' Equity (Unaudited)

v3.23.1
Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance of common stock (in shares) at Dec. 31, 2021   72,027,743      
Beginning balance of stockholders' equity at Dec. 31, 2021 $ 256,208 $ 7 $ 401,702 $ (3,463) $ (142,038)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Foreign currency translation adjustment (123)     (123)  
Stock-based compensation 2,050   2,050    
Common stock issued pursuant to acquisition (in shares)   4,212,246      
Common stock issued pursuant to acquisition 23,295 $ 1 23,294    
Net loss (11,572)       (11,572)
Ending balance of common stock (in shares) at Mar. 31, 2022   76,239,989      
Ending balance of stockholders' equity at Mar. 31, 2022 $ 269,858 $ 8 427,046 (3,586) (153,610)
Beginning balance of common stock (in shares) at Dec. 31, 2022 76,292,241 76,292,241      
Beginning balance of stockholders' equity at Dec. 31, 2022 $ 180,672 $ 8 435,292 (6,390) (248,238)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Foreign currency translation adjustment 128     128  
Stock-based compensation 2,570   2,570    
Vesting of restricted stock units (in shares)   395,067      
Shares withheld related to net share settlement (in shares)   (134,713)      
Shares withheld related to net share settlement (185)   (185)    
Net loss $ (18,490)       (18,490)
Ending balance of common stock (in shares) at Mar. 31, 2023 76,552,595 76,552,595      
Ending balance of stockholders' equity at Mar. 31, 2023 $ 164,695 $ 8 $ 437,677 $ (6,262) $ (266,728)